Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > How close are we to needing CASH?
View:
Post by SouthernTierTom on May 07, 2022 9:25am

How close are we to needing CASH?

Are we south of 2M buy the end of May?

Do the math... it is easy... but bear in mind, ramping up clinical activity ramps up cash burn.. at least tip-ically

Help retailers... we do not need a repeat of the mid 50 churn to 30 cent learn we got in 2019. Jmho.. based on historic FACT

Happy Saturday,
Tom-kat ... aka top up the kitty?
Comment by SouthernTierTom on May 08, 2022 11:50am
Wouldn't this question be most important as it pertains to the share price and knowlewdge a retialer needs to make an investment decision?  Most of you appear "novice" and quite frankly "questuoinable" at best....sumfin stinks here on this bull-bored. Cept for Enriqueo, didn't he claim his brother was an urologist from Qeubec? ; - ) Are we south of 2M buy the end ...more  
Comment by enriquesuave on May 08, 2022 12:48pm
8-12 months of cash left as per MD&A. No worries for 6 months at least. By the a hell of a lot can happen. IMO 
Comment by jmm1228 on May 08, 2022 1:13pm
I am no novice - the cash situation should to be taken as potentially devastating. Talk of such has a motive behind it - beware.
Comment by robertshaw on May 08, 2022 2:25pm
no cash needed, enough to finish the 120 patients of Phase 2. Any other rumor talk about financial needed at this level is just Blowjobjoe's bosses bull$hit.
Comment by skys1 on May 08, 2022 2:29pm
I've been around here a long time, plus have been trading financials for almost 60 years. I believe this jmm1228 is short, and or a basher. Think of what would be his motivation for such a post???
Comment by Rumpl3StiltSkin on May 08, 2022 3:24pm
Agreed Skys, Burn rate would suggest being low on $$ at year end. I do think TLT is soo close to commercialization that they have something lined up. Or they will... :-) Not a happy time for shorters of TLT.
Comment by jmm1228 on May 08, 2022 3:44pm
Have advanced macular degeneration which compels me to proof read all my posts before putting them up. Did not on the former.. THERE IS NO DAMNING CASH ISSUE, MANY ARE THE OPTIONS TLT IS IN A POSITION TO PURSUE. ANYONE  POSTING SUCH NONSENSE HAS AN INSIDIOUS MOTIVE.  TLT has the goods in a field notorious for an excruciating trial process and is near securing vital recognition. Amen.
Comment by Eoganacht on May 08, 2022 6:16pm
Hi jmm1228.  Most definitely a typo. You missed one letter and transposed two other letters and all of a sudden you look like a basher.
Comment by Yajne on May 08, 2022 10:39pm
Thanks Eogan. Based on my past knowledge of jmm1228 I thought it might be a mistake. I can't see the first couple posts on this thread so don't know who started this non-sensicle discussion. Guessing it was a guy named southern tom or something like that. He has usually been the one to stir the pot on such issues. If it was him, I always thought he had an AGENDA, which is why he sits on my ...more  
Comment by SouthernTierTom on May 08, 2022 3:19pm
I think many of you FAIL to understand the costs associated with FDA trials )(actually, you "pretend to") .  I've been around the bio-game for a very long time and have a rather exceptional memory and track record of calling out unethical games played on this very bullboard. The last time they raised, the cash was around 1.5 M CAD, we will be there in relatively short order ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250